Struktur Dan Fungsi Retikulum Endoplasma Pdf Free
Hermelindo Sauceda
Struktur Dan Fungsi Retikulum Endoplasma Pdf Free
If you are interested in learning about the structure and function of the endoplasmic reticulum, a complex organelle in eukaryotic cells, you can download this free pdf that will explain everything you need to know. The endoplasmic reticulum (ER) is a network of membranes that performs various roles in the cell, such as producing and transporting proteins, lipids, and carbohydrates, storing calcium, and detoxifying substances . The ER has two main types: the rough ER and the smooth ER, which differ in their structure and function . In this article, we will explore the structure and function of each type of ER and how they contribute to the cellular activities.
Structure of the Endoplasmic Reticulum
The ER is composed of cisternae, which are flattened sacs of membranes that form tubules and vesicles. The ER is connected to the nuclear envelope, which is the membrane that surrounds the nucleus of the cell. The space between the two membranes of the nuclear envelope is continuous with the space inside the cisternae of the ER. The ER can be divided into two regions: the rough ER and the smooth ER, based on the presence or absence of ribosomes on their surface . Ribosomes are small structures that synthesize proteins from amino acids.
Rough Endoplasmic Reticulum
The rough ER (RER) is the part of the ER that has ribosomes attached to its cytoplasmic side . The RER is responsible for producing proteins that are destined for secretion or insertion into membranes . For example, some cells in the pancreas secrete digestive enzymes that are synthesized by the ribosomes on the RER. The ribosomes on the RER grow polypeptide chains from amino acids and insert them into the cisternal space through a pore. The polypeptide chains then fold into their proper conformation inside the cisternae. Some proteins are modified by attaching carbohydrates to them, forming glycoproteins . The carbohydrates are added by enzymes that are embedded in the RER membrane. The glycoproteins are then transported to the Golgi complex, another organelle that further modifies and sorts them before they are released from the cell .
Smooth Endoplasmic Reticulum
The smooth ER (SER) is the part of the ER that lacks ribosomes on its surface . The SER has various functions depending on the cell type, but generally it is involved in synthesizing lipids and carbohydrates, storing calcium, and detoxifying substances . For example, some cells in the liver have abundant SER that breaks down toxins and drugs into harmless products. The SER also produces lipids such as phospholipids and cholesterol, which are essential components of cell membranes . The SER also synthesizes carbohydrates such as glucose and glycogen, which are used for energy storage and metabolism . The SER also stores calcium ions, which are important for muscle contraction and signal transduction . The SER can release or sequester calcium ions depending on the needs of the cell .
Diseases of the Endoplasmic Reticulum
The ER is essential for the proper functioning of the cell, and any disturbance in its structure or function can have serious consequences for the cell and the organism. There are many diseases that are associated with ER dysfunction, especially in the nervous system, where neurons are highly dependent on the ER for protein synthesis and calcium homeostasis. Some of these diseases are:
Cerebral Ischaemia
Cerebral ischaemia is a condition in which the blood supply to the brain is reduced, causing oxygen and nutrient deprivation to the brain tissue. This can result from stroke, cardiac arrest, or traumatic brain injury. Cerebral ischaemia triggers ER stress, which activates the unfolded protein response (UPR), a cellular mechanism that tries to restore ER function by reducing protein synthesis, increasing protein degradation, and enhancing protein folding. However, if the ER stress is prolonged or severe, the UPR can also induce cell death by activating apoptotic pathways. Therefore, modulating the UPR might be a potential therapeutic strategy for cerebral ischaemia.
Alzheimer's Disease
Alzheimer's disease is a neurodegenerative disorder characterized by progressive cognitive decline and memory loss. It is associated with the accumulation of amyloid beta (Aβ) peptides, which are derived from the cleavage of amyloid precursor protein (APP) by secretases. Aβ peptides can form insoluble aggregates that deposit in the brain as amyloid plaques. Aβ peptides can also induce ER stress by interfering with protein folding and calcium regulation in the ER. This leads to the activation of the UPR and the subsequent activation of inflammatory and apoptotic pathways that contribute to neuronal damage and death. Therefore, targeting ER stress might be a potential therapeutic strategy for Alzheimer's disease.
Diseases of the Endoplasmic Reticulum
The ER is essential for the proper functioning of the cell, and any disturbance in its structure or function can have serious consequences for the cell and the organism. There are many diseases that are associated with ER dysfunction, especially in the nervous system, where neurons are highly dependent on the ER for protein synthesis and calcium homeostasis. Some of these diseases are:
Cerebral Ischaemia
Cerebral ischaemia is a condition in which the blood supply to the brain is reduced, causing oxygen and nutrient deprivation to the brain tissue. This can result from stroke, cardiac arrest, or traumatic brain injury. Cerebral ischaemia triggers ER stress, which activates the unfolded protein response (UPR), a cellular mechanism that tries to restore ER function by reducing protein synthesis, increasing protein degradation, and enhancing protein folding. However, if the ER stress is prolonged or severe, the UPR can also induce cell death by activating apoptotic pathways. Therefore, modulating the UPR might be a potential therapeutic strategy for cerebral ischaemia.
Alzheimer's Disease
Alzheimer's disease is a neurodegenerative disorder characterized by progressive cognitive decline and memory loss. It is associated with the accumulation of amyloid beta (Aβ) peptides, which are derived from the cleavage of amyloid precursor protein (APP) by secretases. Aβ peptides can form insoluble aggregates that deposit in the brain as amyloid plaques. Aβ peptides can also induce ER stress by interfering with protein folding and calcium regulation in the ER. This leads to the activation of the UPR and the subsequent activation of inflammatory and apoptotic pathways that contribute to neuronal damage and death. Therefore, targeting ER stress might be a potential therapeutic strategy for Alzheimer's disease.
Multiple Sclerosis
Multiple sclerosis (MS) is an autoimmune disorder that affects the central nervous system, causing inflammation and demyelination of nerve fibers. The exact cause of MS is unknown, but genetic and environmental factors are thought to be involved. MS can cause various neurological symptoms, such as vision loss, muscle weakness, fatigue, pain, and cognitive impairment. MS is associated with ER stress in both immune cells and neurons. In immune cells, such as T cells and B cells, ER stress can affect their activation, differentiation, and survival. In neurons, ER stress can impair axonal transport, synaptic transmission, and myelin formation. Moreover, ER stress can induce the production of pro-inflammatory cytokines and chemokines that exacerbate neuroinflammation. Therefore, targeting ER stress might be a potential therapeutic strategy for MS.
Diseases of the Endoplasmic Reticulum
The ER is essential for the proper functioning of the cell, and any disturbance in its structure or function can have serious consequences for the cell and the organism. There are many diseases that are associated with ER dysfunction, especially in the nervous system, where neurons are highly dependent on the ER for protein synthesis and calcium homeostasis. Some of these diseases are:
Cerebral Ischaemia
Cerebral ischaemia is a condition in which the blood supply to the brain is reduced, causing oxygen and nutrient deprivation to the brain tissue. This can result from stroke, cardiac arrest, or traumatic brain injury. Cerebral ischaemia triggers ER stress, which activates the unfolded protein response (UPR), a cellular mechanism that tries to restore ER function by reducing protein synthesis, increasing protein degradation, and enhancing protein folding. However, if the ER stress is prolonged or severe, the UPR can also induce cell death by activating apoptotic pathways. Therefore, modulating the UPR might be a potential therapeutic strategy for cerebral ischaemia.
Alzheimer's Disease
Alzheimer's disease is a neurodegenerative disorder characterized by progressive cognitive decline and memory loss. It is associated with the accumulation of amyloid beta (Aβ) peptides, which are derived from the cleavage of amyloid precursor protein (APP) by secretases. Aβ peptides can form insoluble aggregates that deposit in the brain as amyloid plaques. Aβ peptides can also induce ER stress by interfering with protein folding and calcium regulation in the ER. This leads to the activation of the UPR and the subsequent activation of inflammatory and apoptotic pathways that contribute to neuronal damage and death. Therefore, targeting ER stress might be a potential therapeutic strategy for Alzheimer's disease.
Multiple Sclerosis
Multiple sclerosis (MS) is an autoimmune disorder that affects the central nervous system, causing inflammation and demyelination of nerve fibers. The exact cause of MS is unknown, but genetic and environmental factors are thought to be involved. MS can cause various neurological symptoms, such as vision loss, muscle weakness, fatigue, pain, and cognitive impairment. MS is associated with ER stress in both immune cells and neurons. In immune cells, such as T cells and B cells, ER stress can affect their activation, differentiation, and survival. In neurons, ER stress can impair axonal transport, synaptic transmission, and myelin formation. Moreover, ER stress can induce the production of pro-inflammatory cytokines and chemokines that exacerbate neuroinflammation. Therefore, targeting ER stress might be a potential therapeutic strategy for MS.
Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder that affects motor neurons in the brain and spinal cord. ALS causes progressive muscle weakness, paralysis, and respiratory failure. The majority of ALS cases are sporadic, but about 10% are familial and linked to genetic mutations. Some of these mutations affect proteins that are involved in ER function or interact with ER components. For example, mutations in superoxide dismutase 1 (SOD1), which normally protects cells from oxidative stress, cause misfolding and aggregation of SOD1 in the ER lumen or membrane. This impairs protein trafficking and induces ER stress and UPR activation. Similarly, mutations in TAR DNA-binding protein 43 (TDP-43), which normally regulates gene expression in the nucleus and cytoplasm, cause mislocalization and aggregation of TDP-43 in the cytoplasm or ER membrane. This disrupts RNA metabolism and induces ER stress and UPR activation. Therefore, targeting ER stress might be a potential therapeutic strategy for ALS.
Conclusion
The endoplasmic reticulum is a vital organelle that performs multiple functions in the cell, such as protein synthesis, folding, modification, and transport, lipid and carbohydrate metabolism, calcium storage and release, and detoxification of substances. The ER also communicates with other organelles and the extracellular environment through various signalling pathways. However, the ER is also susceptible to various stressors that can disrupt its homeostasis and impair its functions. ER stress can activate the unfolded protein response, which tries to restore ER function by adjusting the protein-folding capacity of the cell. However, if the ER stress is chronic or severe, the UPR can also trigger cell death by activating apoptotic pathways. ER stress and UPR have been implicated in various neurological diseases, such as cerebral ischaemia, Alzheimer's disease, multiple sclerosis, amyotrophic lateral sclerosis, and others. These diseases can be caused or exacerbated by ER stress, which can affect both immune cells and neurons. Therefore, targeting ER stress and UPR might be a promising therapeutic strategy for these diseases. In this article, we have discussed the structure and function of the ER, the mechanisms of ER stress and UPR, and their roles in neurological diseases. We hope that this article has provided you with useful information and insights on this topic. If you want to learn more about the ER and its related diseases, you can download this free pdf that contains more details and references.
0f8387ec75